/ /

Fedra Pavlou
Fedra Pavlou is the Editor-in-Chief of Ophthalmology Times Europe. She may be reached by Tel: +44 (0)1244 393 420 or E-mail: [email protected]. If you have a general enquiry about Ophthalmology Times Europe, please contact Pamela Brook, Editor ([email protected]).
Farewell... And hello
We welcome OTE's incoming editor, Pam Brook
A year for change
2009 has started with a bang...
How should we be treating our DME patients?
Dr Maeve O'Doherty discusses the literature review she conducted to determine best practice in the treatment of diabetic macular oedema.
Securing success in phaco-trabeculectomy
Dr James Tsai outlines key points to ensure a good outcome.
Going blind: a patient's story
US documentary film director Joseph Lovett discusses his latest film project, which he hopes will change public and ophthalmologists' perception of blindness.
MICS: the European picture
Feature includes: statistics providing a true picture of the number of European surgeons practising MICS; interviews with European experts; why you should adopt the technique; product showcase.
Thank you!
Although we have always received a steady stream of feedback from readers, contributors and industry, never have we been bombarded by so many compliments in such a short space of time as at two recent conferences.
What do you want to see in OTE in 2009?
Fill in OTE's online readership survey for the chance to win €500 Marriott hotel vouchers.
Europe burdened by glaucoma but situation can be changed
The World Glaucoma Day inspired glaucoma specialists around the world to rally local support in order to undertake an enormous task: to reduce the number of people who are unnecessarily going blind from a treatable condition.
Have we found the perfect MICS solution?
The loss of confidence in bimanual microincision surgery over the years has caused many surgeons to seek an alternative approach that balances the advantages of minimally invasive cataract surgery with the safety of a sleeved tip. The hunt is also still on for a multifocal lens that offers good vision across all distances, coupled with a low incidence of side effects.

Poll

View Results